Here are seven news updates for ambulatory surgery center leaders to know for August 18, 2014.
Physicians Realty Trust acquires Michigan ASC.
During the second quarter of 2014, self-managed healthcare real estate company Physicians Realty Trust acquired the Surgical Institute of Monroe (Mich.) Ambulatory Surgery Center facility. The company closed the purchase and master lease of the ASC on July 28. The total purchase price was $6 million with a first year unlevered yield of 8 percent.
Frontier Healthcare opens 10th New York endoscopy center.
Frontier Healthcare Holdings and Brookhaven Gastroenterology Associates have opened the Great South Bay Endoscopy Center in Suffolk County, N.Y. Great South Bay Endoscopy Center is Frontier Healthcare's tenth ASC to open in New York state and the second in Suffolk County.
System-wide SCA revenue up 10%.
System-wide revenue, including all centers in which the company has an interest or manages, rose 10.2 percent. Total net operating revenues, excluding revenues from centers in which SCA does not hold a controlling interest, rose 8 percent from $196.7 million in the second quarter of 2013 to $212.4 million.
Symbion revenue, income rises in 2Q.
The company’s revenue was up 7.5 percent from $132.3 million in the second quarter of 2013 to $142.2 million in the second quarter of 2014. Symbion ended the quarter with $6.6 million in net income, up from $1.5 million in the second quarter of 2013.
FDA approves DNA-based colorectal cancer test.
The FDA has approved stool-based colorectal cancer diagnostic device Cologuard from Exact Sciences. Cologuard is designed to detect colorectal neoplasia and associated DNA markers, as well as the presence of occult hemoglobin. A positive result indicates the presence of colorectal cancer or advanced adenoma. In the case of a positive result, the test is designed to be followed by diagnostic colonoscopy.
20 states allow NPs to prescribe independently.
Nurse practitioners, or advanced practice registered nurses, have varying degrees of practice independence, depending on where they practice medicine. Twenty states grant NPs to the authority to prescribe medications without physician or Board of Medicine involvement. Read the full report on Becker's Hospital Review.
300,000+ must prove PPACA plan eligibility or lose coverage.
About 310,000 people who purchased health plans through the Patient Protection and Affordable Care Act exchanges and qualified for federal subsidies could lose their coverage, unless they provide documentation proving their eligibility. The individuals in question have discrepancies between data on their applications for insurance and government records. Read the full report on Becker's Hospital Review.
More articles on ASC issues:
4 recent ASC industry leadership moves
7 things for ASC leaders to know for Thursday
5 incentives to watch in ASC documentation
Physicians Realty Trust acquires Michigan ASC.
During the second quarter of 2014, self-managed healthcare real estate company Physicians Realty Trust acquired the Surgical Institute of Monroe (Mich.) Ambulatory Surgery Center facility. The company closed the purchase and master lease of the ASC on July 28. The total purchase price was $6 million with a first year unlevered yield of 8 percent.
Frontier Healthcare opens 10th New York endoscopy center.
Frontier Healthcare Holdings and Brookhaven Gastroenterology Associates have opened the Great South Bay Endoscopy Center in Suffolk County, N.Y. Great South Bay Endoscopy Center is Frontier Healthcare's tenth ASC to open in New York state and the second in Suffolk County.
System-wide SCA revenue up 10%.
System-wide revenue, including all centers in which the company has an interest or manages, rose 10.2 percent. Total net operating revenues, excluding revenues from centers in which SCA does not hold a controlling interest, rose 8 percent from $196.7 million in the second quarter of 2013 to $212.4 million.
Symbion revenue, income rises in 2Q.
The company’s revenue was up 7.5 percent from $132.3 million in the second quarter of 2013 to $142.2 million in the second quarter of 2014. Symbion ended the quarter with $6.6 million in net income, up from $1.5 million in the second quarter of 2013.
FDA approves DNA-based colorectal cancer test.
The FDA has approved stool-based colorectal cancer diagnostic device Cologuard from Exact Sciences. Cologuard is designed to detect colorectal neoplasia and associated DNA markers, as well as the presence of occult hemoglobin. A positive result indicates the presence of colorectal cancer or advanced adenoma. In the case of a positive result, the test is designed to be followed by diagnostic colonoscopy.
20 states allow NPs to prescribe independently.
Nurse practitioners, or advanced practice registered nurses, have varying degrees of practice independence, depending on where they practice medicine. Twenty states grant NPs to the authority to prescribe medications without physician or Board of Medicine involvement. Read the full report on Becker's Hospital Review.
300,000+ must prove PPACA plan eligibility or lose coverage.
About 310,000 people who purchased health plans through the Patient Protection and Affordable Care Act exchanges and qualified for federal subsidies could lose their coverage, unless they provide documentation proving their eligibility. The individuals in question have discrepancies between data on their applications for insurance and government records. Read the full report on Becker's Hospital Review.
More articles on ASC issues:
4 recent ASC industry leadership moves
7 things for ASC leaders to know for Thursday
5 incentives to watch in ASC documentation